ArticleThe Journal of clinical investigation2004

The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells.

Shinji Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.